Hong Kong Construction Stock News

China approves CARDAMYST, putting Everest Medicines in focus Everest Medicines (SEHK:1952) just cleared a major hurdle in China, with regulators approving CARDAMYST for at home treatment of acute paroxysmal supraventricular tachycardia episodes in adults. Despite the regulatory win, Everest Medicines shares closed at HK$31.22 after a 1 day share price return that declined 5.5%. However, the 30 day and 90 day share price returns of 10.1% and 13.9% suggest momentum has been building off a...

China Overseas Property Holdings (SEHK:2669) has been dropped from the Hang Seng China Affiliated Corporations Index, an adjustment that can reshape how index-tracking funds treat the stock and influence short term trading flows. At a share price of HK$3.545, China Overseas Property Holdings has seen a 1-month share price return of 4.26% and a 7-day gain of 2.60%. However, the 1-year total shareholder return is down 29.48% and the 3-year total shareholder return has fallen 57.68%, which...

China Everbright Environment Group reported half year 2026 results with sales of HK$14,181.32 million and net income of HK$2,431.24 million, and announced an interim dividend of HK$0.16 per share with an ex dividend date of 21 September 2026 and payment on 20 October 2026. Net income and basic earnings per share from continuing operations both came in higher than the prior year period, which points to tighter execution across the business despite broadly similar revenue. With earnings per...

Beijing Enterprises Water Group Limited announced an interim ordinary cash dividend of HK$0.0554 per share for the six months ended 30 June 2026, with the record date on 10 September 2026 and payment scheduled for 26 October 2026. The lower interim dividend indicates that Beijing Enterprises Water Group may be prioritising balance sheet resilience or funding needs over near term cash returns to shareholders. The next step is to consider how this reduced interim dividend influences Beijing...

Sino Biopharmaceutical recently reported three key pipeline milestones, including positive preclinical data for oral STAT6 degrader TQH5528, FDA IND clearance for GPC3 ADC TQB6426 for advanced tumors, and encouraging Phase I results plus Lancet publication for Lp(a) lowering siRNA Kylo-11. These updates show Sino Biopharmaceutical spreading R&D risk across respiratory, oncology and cardiovascular programs, while moving from platform science into clinically validated, late preclinical and...

Shareholders in China Shenhua Energy Company Limited ( HKG:1088 ) may be thrilled to learn that the analysts have just...

Laopu Gold reported half year 2026 results with sales of CNY 19,808.37 million, net income of CNY 4,267.23 million, and basic EPS of CNY 24.16, and also declared an interim cash dividend of RMB 18.02 per share with payment scheduled for January 22, 2027. The combination of higher earnings per share from continuing operations and a sizable interim dividend suggests Laopu Gold is returning a significant share of recent profits directly to investors. Given this mix of stronger first half...

China Resources Power Holdings reported half year 2026 results with sales of HK$54,976.93 million, net income of HK$6,649.41 million and basic earnings per share of HK$1.28, alongside an interim dividend of HK$0.321 per share. The company coupled these financial updates with a broad reshuffle of independent directors and board committee roles, which may influence how China Resources Power Holdings balances sustainability oversight, remuneration decisions and risk governance going...

Rising odds of a Fed rate hike, gold holding near US$4,400, and fresh geopolitical risk in the Middle East are pulling money toward perceived havens and away from high-octane growth stories. That reshuffle creates both potential safety nets and potential traps. This piece walks through three precious metals stocks from our screener that appear especially exposed to these headlines, so you can decide which opportunities or risks deserve a closer look. The stocks covered below are just a small...

Kingboard Holdings stock reacts to higher interim dividend and half year results Kingboard Holdings (SEHK:148) has come into focus after reporting half year 2026 sales of HK$29,131.39 million and net income of HK$2,711.41 million, alongside declaring an interim dividend of HK$0.73 per share. At a latest share price of HK$52.35, Kingboard Holdings has seen mixed momentum, with a 1 day share price return of 4.18% and a 30 day share price return of 11.05%, while its 90 day share price return...

Why Jinhai Medical Technology’s Latest Half Year Results Matter Jinhai Medical Technology (SEHK:2225) has drawn fresh attention after reporting half year 2026 results. Sales reached SGD 34.02 million while the company reported a reduced net loss of SGD 4.36 million. For investors watching the stock in early September 2026, the combination of higher reported sales and a smaller loss compared with the prior year raises questions about how the business mix and cost base are evolving. Jinhai...

Why BYD Electronic (International) Stock Is Back in Focus BYD Electronic (International) (SEHK:285) is drawing fresh attention after its half year 2026 results showed sales of CNY 82,234.2 million, alongside a sharp drop in net income to CNY 426.33 million. The earnings announcement has arrived after a volatile stretch for BYD Electronic (International). The share price is up 6.84% on the day and has posted a 12.28% 1‑month share price return. However, it remains down 23.81% year to date and...

The renewed debate around Trump-era China tariffs is shining a light on where real capital is actually going. While some US industrials lean more on financial engineering, sections of China’s manufacturing base appear to stay closer to bricks, machines and factories. For investors, that opens up a fresh way to think about long-term exposure to industrial growth. This article walks through three Chinese manufacturing stocks that screen positively against this backdrop. The three stocks...

Akeso’s partner Summit Therapeutics reported that Akeso’s PD-1/VEGF bispecific ivonescimab achieved statistically significant overall survival gains over pembrolizumab and durvalumab in separate Phase III trials for PD-L1 positive non-small cell lung cancer and advanced biliary tract cancer, building on prior progression-free survival wins and recent China approvals. This string of head-to-head successes against current immunotherapy standards of care underscores ivonescimab’s potential to...

Global shipping routes are being reshaped as water shortages at the Panama Canal and rising transit fees ripple through supply chains. That kind of disruption can punish some businesses while creating fresh demand for marine engineering, dredging and water-management solutions. This article explores three stocks exposed to that news, each tied to the infrastructure that keeps trade moving, so you can judge whether they might belong on your watchlist or stay on the sidelines. The stocks...

SenseTime Group Inc. reported past-half-year results for the period ended June 30, 2026, with sales of CNY 2,910.95 million versus CNY 2,358.20 million a year earlier and net income of CNY 607.42 million compared with a net loss of CNY 1,477.95 million. This shift from loss to profit, alongside the move from a basic loss per share of CNY 0.04 to earnings of CNY 0.01, marks a clear operational turnaround. Next, we will examine how this return to profitability shapes SenseTime Group’s...

Meitu (SEHK:1357) has drawn fresh attention after reporting half year 2026 results, with higher sales and net income than a year earlier, alongside an interim cash dividend that returns capital to shareholders. Meitu’s latest half year update comes after a tough stretch for the stock, with the share price down about 35% year to date and the 1 year total shareholder return down about 47%, even though the 3 year and 5 year total shareholder returns remain strongly positive. Compare Meitu’s...

Jaguar Land Rover’s plan to cut 4,000 jobs, tackle cyber vulnerabilities and respond to rising Chinese EV competition has pushed auto risks and opportunities back into focus. When a legacy giant scrambles to protect margins, investors tend to look closely at Chinese Electric Vehicle and Auto Export Leaders that are already geared to this transition. This article walks through three stocks exposed to this news and explains why they may deserve a closer look now. The stocks in the article below...

Half year results put Shanghai Electric Group stock in focus Shanghai Electric Group (SEHK:2727) moved back onto investor radars after half year 2026 earnings on 28 August, with higher reported sales, revenue, net income and earnings per share compared with the prior period. The earnings release has come after a weak stretch for Shanghai Electric Group, with the share price down 26.27% year to date and 23.49% over the past three months, although the 3 year total shareholder return of 71.80%...

Why BOC Hong Kong (Holdings) is Back on Dividend Watch BOC Hong Kong (Holdings) (SEHK:2388) has drawn fresh attention after releasing its half year 2026 earnings, alongside a special cash dividend declaration and an affirmed second interim dividend, which together highlight current shareholder return plans. Those dividend announcements and half year 2026 results arrived after a strong run in the shares, with the latest share price at HK$52.85 and a 31.34% year to date share price return. The...

Dividend and Earnings Announcement Draw Focus to Shanghai Industrial Holdings Shanghai Industrial Holdings (SEHK:363) has put fresh attention on its stock after releasing half year 2026 results alongside an interim dividend of HK$0.42 per share, with payout set for mid October. The company reported sales of HK$8,805.47 million for the six months to 30 June 2026 compared with HK$9,476.03 million a year earlier. Net income was HK$1,057.98 million compared with HK$1,041.8 million, with basic and...

Why First Pacific’s Latest Half Year Earnings Matter For Investors First Pacific (SEHK:142) has drawn fresh attention after reporting half year 2026 results that showed sales of US$5,316.3m alongside net income of US$301.5m, compared with US$5,027.8m and US$391.2m a year earlier. First Pacific’s latest half year results, which showed sales growth alongside lower net income, come with a share price of HK$5.095 and a year-to-date share price return that has fallen 14.66%. The 5-year total...

Laopu Gold earnings jump and interim dividend put income profile in focus Laopu Gold (SEHK:6181) drew fresh attention after reporting higher half year sales and net income for the six months to 30 June 2026, alongside an interim cash dividend of RMB 18.02 per share. The earnings and dividend announcement on 25 August came after a mixed run for Laopu Gold, with the 30 day share price return up 13.44%, but the year to date share price return down 35.95% and the 1 year total shareholder return...

China International Capital (SEHK:3908) reported half year 2026 earnings that caught investor attention, with revenue of CNY 26,047.21m and net income of CNY 8,199.27m compared with the same period a year earlier. Following these results, China International Capital’s share price closed at HK$21.9, with a 1-day share price return of 2.91%. This partly offsets a weaker 7-day share price return of 4.28% and signals some renewed short term interest after the earnings release. Over a longer...